إعلان
إعلان
ATXS
Astria Therapeutics, Inc. Common Stock
12.88
USDبرعاية
-0.09
-0.72%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
12.88
0.00
0.00%
تقارير أرباح ATXS
النسبة الإيجابية المفاجئة
ATXS تفوق 24 من 40 آخر التقديرات.
60%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$3.06M
/-$0.56
التغير الضمني من Q3 25 (Revenue/ EPS)
+333.43%
/+1.82%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+180.00%
Astria Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, ATXS reported earnings of -0.55 USD per share (EPS) for Q3 25, missing the estimate of -0.39 USD, resulting in a -38.12% surprise. Revenue reached 706.00 ألف, compared to an expected 10.88 مليون, with a -93.51% difference. The market reacted with a +0.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.56 USD, with revenue projected to reach 3.06 مليون USD, implying an زيادة of 1.82% EPS, and زيادة of 333.43% in Revenue from the last quarter.
الأسئلة الشائعة
What were Astria Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Astria Therapeutics, Inc. Common Stock reported EPS of -$0.55, missing estimates by -38.12%, and revenue of $706.00K, -93.51% below expectations.
How did the market react to Astria Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 0.32%, changed from $12.51 before the earnings release to $12.55 the day after.
When is Astria Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Astria Therapeutics, Inc. Common Stock's next earnings report?
Based on 9
المحللين, Astria Therapeutics, Inc. Common Stock is expected to report EPS of -$0.56 and revenue of $3.06M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان